Mid West One Financial Group, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Mid West One Financial Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $2,869 - $3,621	-5 Reduced 0.44%	1,123 $774,000
Q2 2022 Aug 16, 2022	SELL	$548.35 - $738.84 $12,063 - $16,254	-22 Reduced 1.91%	1,128 $667,000
Q1 2022 May 17, 2022	BUY	$595.12 - $698.43 $20,829 - $24,445	35 Added 3.14%	1,150 $803,000
Q4 2021 Feb 15, 2022	BUY	$543.48 - $670.97 $71,195 - $87,897	131 Added 13.31%	1,115 $704,000
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $14,924 - $17,704	26 Added 2.71%	984 $595,000
Q2 2021 Aug 17, 2021	SELL	$472.8 - $558.54 $8,983 - $10,612	-19 Reduced 1.94%	958 $535,000
Q1 2021 May 18, 2021	BUY	$446.73 - $548.2 $184,946 - $226,954	414 Added 73.53%	977 $462,000
Q4 2020 Feb 17, 2021	SELL	$478.3 - $607.98 $114,313 - $145,307	-239 Reduced 29.8%	563 $272,000
Q3 2020 Nov 17, 2020	BUY	$544.75 - $658.21 $436,889 - $527,884	802 New	802 $449,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Mid West One Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Mid West One Financial Group, Inc. with notifications on news.